動物治療和診斷市場規模、佔有率和成長分析（按產品、技術、應用、動物種類、最終用途和地區分類）－2026-2033年產業預測

全球獸醫治療和診斷市場規模預計在 2024 年達到 502.8 億美元，從 2025 年的 534.5 億美元成長到 2033 年的 871.4 億美元，在預測期（2026-2033 年）內複合年成長率為 6.3%。

在技​​術創新、監管標準日益嚴格以及對動物健康解決方案需求不斷成長的推動下，全球動物治療診斷市場正經歷顯著成長。產業領導者和研究人員正優先開發智慧診斷系統並整合人工智慧技術，以提高效能並簡化供應鏈流程。機器學習和人工智慧的持續進步正在改變動物健康數據的傳播方式，從而能夠針對特定物種、健康狀況和監管要求提供超精準的即時建議。這項技術變革不僅提高了診斷的準確性和效率，還有助於更快、更有效地進行動物健康管理，為未來市場的持續發展和創新奠定了基礎。

推動全球動物治療診斷市場發展的因素

受人們對伴侶動物觀念轉變的推動，全球獸醫治療和診斷市場正經歷顯著成長。寵物越來越被視為家庭成員，尤其是在北美、歐洲和亞太地區。這種轉變推動了對動物健康的高級治療和診斷解決方案的需求。已開發國家擁有較高的可支配收入，正加速採用創新護理方案；而在開發中國家，飼主數量的增加也促使人們提高照護標準。這兩種趨勢共同推動了獸醫保健產業的市場擴張和創新。

全球動物治療和診斷市場面臨的限制因素

全球獸醫治療和診斷市場面臨嚴峻挑戰，這主要是由於生物製藥、細胞療法等先進治療技術以及精密診斷技術的前期成本高昂。這種經濟負擔會限制市場成長，尤其會影響發展中地區的小規模獨立獸醫診所和機構。因此，這些高效解決方案的應用往往僅限於大規模獸醫醫院網路和研究機構。除非出現更具擴充性和成本效益的創新技術，否則市場可能無法充分發揮其潛力，從而限制更多醫療保健專業人員獲得這些先進的治療方法和診斷工具。

全球動物治療與診斷市場趨勢

全球動物治療診斷市場正日益受到旨在提升動物健康管理的數位化平台的推動。先進數位工具的整合正在透過提高效率和改善診斷準確性來改變傳統的獸醫實踐。這一趨勢在伴侶動物和畜牧管理領域尤其明顯，這主要得益於寵物科技解決方案的廣泛應用。隨著相關人員逐漸認知到互聯智慧獸醫解決方案的價值，對創新診斷技術的需求預計將會成長。這將有助於制定更積極主動的健康管理和治療策略，從而重塑動物醫療保健的提供方式。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境
• 客戶和購買標準分析

全球動物治療和診斷市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 消耗品
• 裝置

全球動物治療及診斷市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 臨床生物化學
  • 血糖監測
  • 血氣和電解質分析
  • 其他臨床生物化學檢驗
• 免疫診斷
  • 橫向流動化驗
  • ELISA
  • 免疫檢測裝置
  • 其他免疫診斷測試
• 分子診斷
  • PCR
  • 微陣列
  • 其他分子診斷測試
• 血液學
• 尿液檢查
• 其他技術

全球動物治療及診斷市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 細菌學
• 病理
• 寄生蟲學
• 其他用途

全球動物治療及診斷市場規模（按動物類型分類）及複合年成長率（2026-2033 年）

• 伴侶動物
  • 狗
  • 貓
  • 馬
  • 其他伴侶動物
• 家畜
  • 牛
  • 豬
  • 家禽
  • 其他家畜

全球動物治療和診斷市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 獸醫醫院和診所
• 診斷檢查室
• 居家醫療環境
• 其他用途

全球動物治療及診斷市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Zoetis（USA）
• Merck Animal Health（USA）
• Boehringer Ingelheim（Germany）
• Elanco（USA）
• IDEXX Laboratories（USA）
• Virbac（France）
• Ceva Sante Animale（France）
• Dechra Pharmaceuticals（UK）
• Vetoquinol（France）
• Phibro Animal Health（USA）
• Heska Corporation（USA）
• Neogen（USA）
• Covetrus（USA）
• Thermo Fisher Scientific（USA）
• ImmuCell（USA）
• B. Braun Vet Care（Germany）
• Huvepharma（Bulgaria）
• Indian Immunologicals Limited（India）
• Zoetis Animal Health India Pvt. Ltd.（India）
• Inmed Animal Health（India）

結論與建議

Global Animal Therapeutics Diagnostics Market size was valued at USD 50.28 Billion in 2024 and is poised to grow from USD 53.45 Billion in 2025 to USD 87.14 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The global animal therapeutics diagnostics market is experiencing significant growth due to technological innovation, heightened regulatory standards, and a rising demand for animal health solutions. Industry leaders and researchers are prioritizing the development of intelligent diagnostic systems and the integration of AI-driven technologies to enhance performance and streamline supply chain processes. Continued advancements in machine learning and artificial intelligence are transforming the dissemination of animal health data, allowing for hyper-targeted, real-time recommendations tailored to specific species, health conditions, and regulatory requirements. This evolution in technology is not only improving diagnostic accuracy and efficiency but also fostering a more responsive and effective approach to animal health management, positioning the market for sustained progress and innovation in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Therapeutics Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Therapeutics Diagnostics Market Segments Analysis

Global Animal Therapeutics Diagnostics Market is segmented by Product, Technology, Application, Animal Type, End Use and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Molecular diagnostics, Hematology, Urinalysis and Other technologies. Based on Application, the market is segmented into Bacteriology, Pathology, Parasitology and Other applications. Based on Animal Type, the market is segmented into Companion animals and Farm animals. Based on End Use, the market is segmented into Veterinary hospitals and clinics, Diagnostic labs, Home care settings and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market is experiencing significant growth driven by an evolving perception of companion animals. Pets are increasingly regarded as integral members of the family, particularly in regions such as North America, Europe, and Asia-Pacific. This shift has led to heightened demand for advanced therapeutics and diagnostics solutions tailored to animal health. In developed countries with greater disposable incomes, there is a robust adoption of innovative care options, while in developing nations, the growing pet population is prompting owners to enhance their care standards. This dual dynamic propels market expansion and innovation within the animal health sector.

Restraints in the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market faces notable challenges due to the substantial upfront costs associated with advanced therapeutics, such as biologics and cell-based therapies, along with sophisticated diagnostic technologies. This financial burden can restrict market growth, particularly impacting smaller independent veterinary clinics and veterinary practices in developing regions. Consequently, the adoption of these high-efficacy solutions tends to be largely confined to larger veterinary hospital networks and research facilities. Without the emergence of more scalable and cost-effective innovations, the market might struggle to achieve its full potential, limiting access to these advanced treatments and diagnostic tools for a broader range of practitioners.

Market Trends of the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market is increasingly influenced by the surge in digital platforms aimed at enhancing animal health management. The integration of advanced digital tools is transforming traditional veterinary practices by promoting efficiency and improving diagnostic accuracy. This trend is particularly pronounced in both companion animal and livestock management sectors, driven by the growing adoption of pet-tech solutions. As stakeholders recognize the value of connected, smart veterinary solutions, the demand for innovative diagnostic technologies is expected to rise, facilitating more proactive health management and treatment strategies, thereby reshaping the landscape of animal healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Global Animal Therapeutics Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments

Global Animal Therapeutics Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Clinical biochemistry
  • Glucose monitoring
  • Blood gas and electrolyte analysis
  • Other clinical biochemistry tests
• Immunodiagnostics
  • Lateral flow assays
  • ELISA
  • Immunoassay analyzers
  • Other immunodiagnostic tests
• Molecular diagnostics
  • PCR
  • Microarrays
  • Other molecular diagnostic tests
• Hematology
• Urinalysis
• Other technologies

Global Animal Therapeutics Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Bacteriology
• Pathology
• Parasitology
• Other applications

Global Animal Therapeutics Diagnostics Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion animals
  • Dogs
  • Cats
  • Horses
  • Other companion animals
• Farm animals
  • Cattle
  • Swine
  • Poultry
  • Other farm animals

Global Animal Therapeutics Diagnostics Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Veterinary hospitals and clinics
• Diagnostic labs
• Home care settings
• Other end use

Global Animal Therapeutics Diagnostics Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, Animal Type, End Use)
  • US
  • Canada
• Europe (Product, Technology, Application, Animal Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, Animal Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, Animal Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, Animal Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ImmuCell (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Vet Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Animal Health India Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inmed Animal Health (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations